Autopsy report · NCT02044926

Intraductal Papillary Mucinous Neoplasm With Malignant Change

“Because patient enrollment is so difficult.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 6 months before it stopped.
• 54 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Asan Medical Center

Sponsor type

University, hospital or other

Conditions

IPMN

Participants

54

Sites

1

Countries

South Korea

Trials that died the same way

• Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
  “Lack of Patient Enrollment” (79% match in meaning)
• Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
  “due to the difficulty to enroll suitable patients” (79% match in meaning)
• Wellness Initiative at New York University
  “Due to inability to enroll patients” (77% match in meaning)
• The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients
  “Low enrollment -- We could not recruit patients willing to be enrolled” (76% match in meaning)
• Safe and Effective Sedation in Chronic Alcoholic Patients Underwent Diagnostic Endoscopic Procedures: Study Comparing Midazolam and Propofol With Midazolam
  “because of difficulties for participants enrollment” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.